Table 1.
Numbers of mice used in behavioral studies
Figure | Treatment in mice | Serotonergic dose and n values | ||||
---|---|---|---|---|---|---|
1A,B | 5-HTP (mg/kg, i.p.) ±M100 | 100 | 150 | 200 | M100 + 200 | |
WT, βarr2-KO | n = 13, 8 | n = 7, 5 | n = 8, 7 | n = 6, 6 | ||
1C,D | 5-HT (μg, i.c.v.) ±M100 | 10 | 20 | 40 | M100 + 40 | |
WT, βarr2-KO | n = 4, 5 | n = 7, 5 | n = 5, 6 | n = 4, 4 | ||
1E,F | Veh/Clor (±M100) + 5-HTP | Veh +50 | Veh +100 | Clor +50 | Clor +100 | Clor + M100 +100 |
WT, βarr2-KO | n = 6, 5 | n = 6, 5 | n = 5, 6 | n = 9, 8 | n = 4, 4 | |
2A,B | Veh/MTZ + 5-HTP | Veh + 200 | MTZ + 200 | |||
WT, βarr2-KO | n = 4, 5 | n = 4, 5 | ||||
3A,B | N-Me-5-HT (μg, i.c.v.) | 10 | 20 | 40 | ||
WT, βarr2-KO | n = 4, 4 | n = 5, 5 | n = 4, 4 | |||
3C | Veh/M100 + N-Me-5-HT | Veh + 20 | M100 + 20 | |||
WT, βarr2-KO | n = 4, 4 | n = 4, 4 | ||||
3D | Veh/MTZ + N-Me-5-HT | Veh + 20 | MTZ + 20 | |||
WT | n = 5 | n = 4 | ||||
3E,F | 5-MeO-DMT (mg/kg, i.p.) | 5 | 10 | 15 | ||
WT, βarr2-KO | n = 9, 10 | n = 10, 16 | n = 5, 5 | |||
3G | Veh/M100 + 5-MeO-DMT | Veh + 10 | M100 + 10 | |||
WT, βarr2-KO | n = 5, 9 | n = 5, 5 | ||||
3H | Veh/MTZ + 5-MeO-DMT | Veh + 10 | MTZ + 10 | |||
C57BL/6 | n = 6 | n = 4 | ||||
6A,B | Veh, LY, PP2, AKTi + 5-HTP | Veh + 200 | LY + 200 | PP2 + 200 | AKTi + 200 | |
C57BL/6 | n = 10 | n = 5 | n = 5 | n = 5 | ||
6C | Veh, AKTi + 5-MeO-DMT | 10 | AKTi + 200 | |||
C57BL/6 | n = 6 | n = 4 | ||||
7A,B | Veh, LY, PP2, AKTi + 5-HTP | 200 | LY + 200 | PP2 + 200 | AKTi + 200 | |
βbarr2-KO | n = 7 | n = 6 | n = 6 | n = 6 | ||
8A,B | Veh, AKTi, MTZ, AKTi + MTZ + 5-HTP | 200 | MTZ + 200 | AKTi + 200 | MTZ + AKTi +200 | |
WT | n = 11 | n = 6 | n = 5 | n = 5 |
Veh, Vehicle; 5-HT, serotonin; M100, M100907; Clor, clorgyline; N-Me-5-HT, N-methylserotonin; LY, LY294002. Serotonergic dosing routes: 5-HTP, mg/kg, i.p.; 5-HT and N-methylserotonin, μg, i.c.v.; 5-MeO-DMT, mg/kg, i.p. For inhibitor and antagonist dosage information, see Materials and Methods.